ANIP·00182C103·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
ANIP (ANI PHARMACEUTICALS INC) is held by 139 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($211.3M), STATE STREET CORP ($59.3M), MILLENNIUM MANAGEMENT LLC ($45.5M). Net institutional sentiment: Mixed.
See how ANIP's score breaks down across 4 SEC sources
Showing 1-20 of 155
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer